Press Release: Align Technology to Announce Fourth Quarter and 2024 Results on February 5, 2025

Dow Jones01-02

Align Technology to Announce Fourth Quarter and 2024 Results on February 5, 2025

TEMPE, Ariz.--(BUSINESS WIRE)--January 02, 2025-- 

Align Technology, Inc. (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign$(R)$ System of clear aligners, iTero$(TM)$ intraoral scanners, and exocad(TM) CAD/CAM software for digital orthodontics and restorative dentistry, today announced that it will report fourth quarter and 2024 financial results on Wednesday, February 5, 2025, after the close of market. Financial results will be released at 4:00 p.m. ET (2:00 p.m. MT) and will be available on the Investor Relations section of the Align website at http://investor.aligntech.com.

Following the press release, Align will host a conference call to discuss its financial results. The conference call will begin at 4:30 p.m. ET (2:30 p.m. MT) and will also be available as an audio webcast live via the Internet. Participants may pre-register for the call by clicking here. The call will also be accessible via webcast on the Investor Relations section of Align Technology's website or by visiting http://investor.aligntech.com. An archived audio webcast will be available two hours after the call's conclusion and will remain available for one month.

For planning purposes, Align is also announcing tentative earnings release dates for fiscal 2025. The official earnings date for each quarter will be announced separately with the corresponding conference call information.

Fiscal Quarters Tentative Dates

First-quarter 2025 (Q1'25) Wednesday, April 30, 2025

Second-quarter 2025 (Q2'25) Wednesday, July 30, 2025

Third-quarter 2025 (Q3'25) Wednesday, October 29, 2025

About Align Technology, Inc.

Align Technology designs and manufactures the Invisalign(R) System, the most advanced clear aligner system in the world, iTero(TM) intraoral scanners and services, and exocad(TM) CAD/CAM software. These technology building blocks enable enhanced digital orthodontic and restorative workflows to improve patient outcomes and practice efficiencies for over 271 thousand doctor customers and are key to accessing Align's 600 million consumer market opportunity worldwide. Over the past 27 years, Align has helped doctors treat approximately 18.9 million patients with the Invisalign System and is driving the evolution in digital dentistry through the Align(TM) Digital Platform, our integrated suite of unique, proprietary technologies and services delivered as a seamless, end-to-end solution for patients and consumers, orthodontists and GP dentists, and lab/partners. Visit www.aligntech.com for more information.

For additional information about the Invisalign System or to find an Invisalign doctor in your area, please visit www.invisalign.com. For additional information about the iTero digital scanning system, please visit www.itero.com. For additional information about exocad dental CAD/CAM offerings and a list of exocad reseller partners, please visit www.exocad.com.

Invisalign, iTero, exocad, Align, and Align Digital Platform are trademarks of Align Technology, Inc.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250102024358/en/

 
    CONTACT:    Align Technology 

Madelyn Valente

(909) 833-5839

mvalente@aligntech.com

Zeno Group

Sarah Karlson

(828) 551-4201

sarah.karlson@zenogroup.com

 
 

(END) Dow Jones Newswires

January 02, 2025 08:31 ET (13:31 GMT)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment